Encompassing the broad spectrum of epigenetics research from basic research to innovations towards therapeutic treatments, Epigenetics Communications is an innovative new, open-access journal devoted to the study of epigenetic principles and mechanisms in basic research settings. In support of open science initiatives, the journal will have a level 4 data policy requiring data be made publically available. The journal is divided into the following sections:
- Molecular Epigenetics (Histone Modifications; DNA Methylation; DNA Demethylation)
- Nuclear Organization
- Mitotic & Meiotic Heritability
- Epigenetic Drugs
- Epigenetic Technologies
- Epigenetic Bioengineering
- Network Epigenetics
- Computational Epigenomics
- Single Cell Epigenetics
- Epigenetic Toxicology
- Model Organisms (Vertebrates; Invertebrates; Plants; Unicellular systems)
Epigenetics Communications will support the publication of manuscripts that contribute to a further understanding of epigenetic mechanisms that impact functioning of systems and organisms. Submissions describing clinical applications are referred to the sister journal, Clinical Epigenetics.
This new and innovative journal will also act as a forum to showcase and discuss alternative conclusions/interpretations of well-established epigenetic phenomena based on (re-)analyses of published or new data. As such, we welcome 'systematic studies', be it positive (expected) or negative (non-expected) with respect to its outcome.